To make cell therapies accessible for a global patient population by controlling growth with Osilaris automated scalable bioreactor for cell therapy manufacturing.
PamDx offers a blood-based immunotherapy guidance test, the IOpener®. The company’s kinase-activity profiling technology and software algorithms support clinicians in their treatment decisions.